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One clue regarding the basis of cocaine-induced deﬁcits in attentional processing is pro-
vided by the clinical ﬁndings of changes in the infants’ startle response; observations
buttressed by neurophysiological evidence of alterations in brainstem transmission time.
Using the IV route of administration and doses that mimic the peak arterial levels of
cocaine use in humans, the present study examined the effects of prenatal cocaine on
auditory information processing via tests of the auditory startle response (ASR), habitu-
ation, and prepulse inhibition (PPI) in the offspring. Nulliparous Long–Evans female rats,
implanted with an IV access port prior to breeding, were administered saline, 0.5, 1.0, or
3.0mg/kg/injection of cocaine HCL (COC) from gestation day (GD) 8–20 (1×/day-GD8–14,
2×/day-GD15–20). COC had no signiﬁcant effects on maternal/litter parameters or growth
of the offspring. At 18–20 days of age, one male and one female, randomly selected from
each litter displayed an increasedASR (>30% for males at 1.0mg/kg and>30% for females
at 3.0mg/kg). When reassessed in adulthood (D90–100), a linear dose–response increase
was noted on response amplitude. At both test ages, within-session habituation was
retarded by prenatal cocaine treatment. Testing the females in diestrus vs. estrus did not
alter the results. Prenatal cocaine altered the PPI response function across interstimulus
interval and induced signiﬁcant sex-dependent changes in response latency. Idazoxan, an
α2-adrenergic receptor antagonist, signiﬁcantly enhanced the ASR, but less enhancement
was noted with increasing doses of prenatal cocaine. Thus, in utero exposure to cocaine,
when delivered via a protocol designed to capture prominent features of recreational usage,
causes persistent, if not permanent, alterations in auditory information processing, and
suggests dysfunction of the central noradrenergic circuitry modulating, if not mediating,
these responses.
Keywords: prenatal cocaine, intravenous administration, auditory startle, habituation, prepulse inhibition, dose–
response, norepinephrine, idazoxan
INTRODUCTION
Although a variety of data sources suggest that the years of 1979–
1985 marked the height of the past epidemic of cocaine abuse in
the U.S., the extraordinary levels of cocaine availability, increased
purity, and the facility of smoking “crack” continue to captivate a
signiﬁcant segment of our population. The population of young
female drug users entering childbearing age is a major concern. In
2009, an estimated 21.8 million Americans aged 12 or older were
current (past month) illicit drug users, meaning they had used an
illicit drug during the month prior to the survey interview (Sub-
stance Abuse and Mental Health Services Administration, 2010).
This estimate represents 8.7% of the population aged 12 years old
or older. Regarding cocaine usage, there are 1.6 million current
cocaine users aged 12 or older, comprising 0.7% of the popula-
tion (Johnston et al., 2010). These estimates are similar to the
number and rate in 2008 (1.9 million or 0.7%). Clearly, illicit
drug abuse, including cocaine/crack use, among young women of
childbearing age remains a signiﬁcant societal concern, placing
future generations at risk. Comprehending the effects of prenatal
drug exposure, such as cocaine/crack, on behavioral and neural
development remains extremely important.
Drug use around the world is not distributed evenly and is not
simply related to drug policy, as countries with more strict user-
level drug policies did not have lower levels of use than countries
with more liberal policies. Of the 17 countries participating in
the World Health Organization’s (WHO’s) World Mental Health
(WMH) Survey Initiative, the highest lifetime cumulative inci-
dence of cocaine was in the United States (16.2%), followed by
New Zealand, Spain, Colombia, and Mexico (range of 4.0–4.3%;
Degenhardt et al., 2008).Amore recent review of countries around
the world has suggested high lifetime prevalence use of cocaine in
Argentina (7.9%), Italy (6.6%), United Kingdom (6.5%), Chile
(5.9%), and Ireland 5.3%; (Degenhardt et al., 2011). Thus, the
implication of cocaine abuse for future generations appears to be
far more than a U.S. health issue.
Comprehensive literature reviews providing∼15 and∼20 year
perspectives on preschool (<6 years of age, Frank et al., 2001)
and school-aged (>6 years of age, Ackerman et al., 2010) prenatal
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cocaine-exposed children, respectively, have failed to deﬁnitively
identify any unique constellation of effects of prenatal cocaine
exposure. Many ﬁndings once thought to be speciﬁc effects of
in utero cocaine exposure are correlated with other factors, includ-
ing prenatal exposure to tobacco, marijuana, or alcohol, and/or a
host of social/environmental factors, such as poverty, caregiver
education, placement stability, and quality of child-caregiver rela-
tionships that are known to affect a child’s development. For
example, among children aged 6 years or younger, across four
domains (physical growth; cognition; language skills; motor skills)
Frank et al. (2001) concluded there was no convincing evidence
that prenatal cocaine exposure is associated with developmental
toxic effects that are different in severity, scope, or kind from the
sequelae of multiple other risk factors. A similar recent reafﬁr-
mation noted that studies of school-aged children have shown no
long-term direct effects of prenatal cocaine exposure on children’s
physical growth, developmental test scores, or language outcomes
(Ackerman et al., 2010).
Nevertheless, the most consistently suggested, and perhaps the
most prominent, fetal cocaine effect reported to date is that of
an enduring attentional dysfunction in preschool and school-
aged children. Problems with attentional processes have been
documented over the past 15 years with several different para-
digms, including computer-controlled continuous performance
tasks (Richardson et al., 1996; Heffelﬁnger et al., 1997, 2002; Leech
et al., 1999; Bandstra et al., 2001; Noland et al., 2005; Savage et al.,
2005; Accornero et al., 2007; Chiriboga et al., 2009; Carmody et al.,
2011). Given the myriad of correlated factors that often char-
acterizes this population, as discussed above, preclinical studies
are important in deﬁning and characterizing the behavioral and
neural basis(es) of alterations in attentional processes. Consistent
alterations in “attentionally sensitive” neurobehavioral paradigms
have been reported in rodents when maternal cocaine was admin-
istered via the intravenous route and at relatively low“recreational”
doses (Mactutus,1999;Bayer et al., 2000,2002;Garavan et al., 2000;
Morgan et al., 2002; Gendle et al., 2003, 2004a,1996; Foltz et al.,
2004).
One clue as to the basis for the cocaine-induced deﬁcits in
attention is provided by the clinical ﬁndings of changes in the
infant’s startle response as well as in neurophysiological evidence
of alterations in brainstem transmission time. Initial clinical stud-
ies suggested an altered startle reactivity to a variety of stimuli
(e.g., Chasnoff et al., 1985, 1989; Grifﬁth, 1988) and impairments
in auditory information processing, characterized by impaired
habituation in infancy (Potter et al., 2000). Although ordinal mea-
surement of Brazelton BehavioralAssessment Scale remains rather
subjective and is a caveat of the earlier studies, reﬂex modiﬁcation
procedures also reported cocaine-exposed infants were more reac-
tive (glabellar reﬂex) and more responsive to auditory stimuli, as
indicated by an increased blink when the tone accompanied the
tap (Anday et al., 1989). Signiﬁcantly depressed startle reactiv-
ity has also been reported in prenatal cocaine-exposed children
at 54months (Mayes et al., 1998). Although there are neither
striking nor consistent data across the various rodent models
to corroborate the clinical in utero cocaine effects on the infant
startle response or its plasticity (Foss and Riley, 1988, 1991a,b;
Dow-Edwards and Hughes, 1995; Vorhees et al., 1995, 2000;
Hughes et al., 1996; Overstreet et al., 2000), to the best of our
knowledge, there is no preclinical data available with the more
clinically relevant intravenous route of cocaine administration.
Neurophysiologically based clinical studies have consistently
reported alterations in auditory brainstem responses (ABR, or also
called brainstem auditory-evoked responses) in prenatal cocaine-
exposed infants (Shih et al., 1988; Salamy et al., 1990;Cone-Wesson
and Spingarn, 1993; Lester et al., 2003; Tan-Laxa et al., 2004).
Prolonged interpeak latencies of the ABR of infants prenatally
cocaine-exposed was reported relative to non-exposed controls
(Shih et al., 1988) and replicated in both termand low-birthweight
infants exposed in utero to cocaine (Salamy et al., 1990) as well as
in infants matched for birth weight and conceptual age (Cone-
Wesson and Spingarn, 1993). No increased incidence of hearing
impairment was found in these early clinical studies. Further, the
one report that failed to ﬁnd effects of prenatal cocaine exposure
on the ABR used relatively low intensity stimuli (30 dB) as the
aim of that study was to ascertain if there were hearing deﬁcits
consequent to prenatal cocaine exposure (Carzoli et al., 1991).
Tan-Laxa et al. (2004) reported abnormal interpeak latencies in
prenatal cocaine-exposed neonates, compared with non-exposed
controls, conﬁrmed with meconium drug analysis. Lester et al.
(2003) conﬁrmed and expanded the effects of prenatal cocaine on
prolonging ABR interpeak latencies at 1month of age, and did so
in a large sample in which covariate adjustments were made (other
drugs, gestational age, social class); the main effects were attribut-
able to heavy maternal cocaine use. Prolonged interpeak latencies,
particularly as a function of increasing stimulation rates, may
indicate that neural recovery time is slower for prenatal cocaine-
exposed infants, such as attributable to neurotransmitter depletion
or dysfunction. Prolongation of the I–V latency, which provides
information regarding the integrity of the eighth cranial nerve to
the auditory brain stem, may indicate delayed brainstem auditory
system development (Salamy, 1984; Krumholz et al., 1985). In a
rodent model, prolongation of the interpeak latencies was also
observed as a function of prenatal cocaine exposure, but only at
the highest dose (100mg/kg/day, subcutaneous), only at 35 days of
age (not at 6–10months of age), and only at the highest stimulus
intensity (Church and Overbeck, 1990). The consistent ABR evi-
dence with in utero cocaine-exposed infants, in conjunction with
the limited animal model data, collectively suggests an ontogenetic
impairment in auditory information processing.
Auditory processing disorders are commonly thought to be
the basis of some language problems. Rate of processing of brief,
rapidly presented, non-linguistic auditory stimuli in infancy has
been shown to the single best predictor of subsequent language
development (Benasich and Tallal, 2002). Although the effects of
prenatal cocaine on preschool language development are com-
monly referred to as equivocal and/or subtle (e.g., Singer et al.,
2001; Beeghly et al., 2006; Dinehart et al., 2009), it is of partic-
ular note that signiﬁcant positive associations of language decre-
ments with prenatal cocaine are reported in covariate-controlled
prospective studies by Singer’s group (Singer et al., 2001; Lewis
et al., 2004, 2007, 2011) and by Bandstra’s group (Bandstra et al.,
2002, 2004, 2011; Morrow et al., 2003, 2004). Not surprisingly,
other large covariate-controlled prospective studies failed to ﬁnd
such effects, as documented by Hurt and colleagues (Hurt et al.,
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1997, 2009; Betancourt et al., 2011), the cohort studied by Frank
and colleagues (Frank et al., 2005; Beeghly et al., 2006) and by
others (Delaney-Black et al., 2000; Kilbride et al., 2000, 2006). One
possible mitigating factor in the disparate outcomes on language
development within the larger prospective longitudinal studies is
that of retention rate. Clearly, retention has been high among those
studies that have reported positive associations of prenatal cocaine
with language decrements (e.g., 89% of infant cohort assessed at
3 years, Morrow et al., 2004; 79% of the original cohort available
for follow up at 3, 5, and 7 years, Bandstra et al., 2004; 77% of the
original cohort through 10 years, Lewis et al., 2011). Although it is
tempting to argue that the absence of an effect of prenatal cocaine
on language may reﬂect low retention rates, e.g., 55%, this lowest
rate was across 20 years (Betancourt et al., 2011). Perhaps most
importantly, to the best of our knowledge, none of the large scale
prospective studies have reported any differential effect of prena-
tal cocaine on retention rates. Collectively, these studies suggest
that if an effect of prenatal cocaine on language is detected in a
study cohort, a stable language decrement will likely be observed
through to adolescence.
Because of these clinical and preclinical reports of prenatal
cocaine-induced alterations in attentional processes and auditory
information processing (with implications for receptive language
development), and that the regulation of sensory processing serves
as a gating mechanism to optimize attention, the present paper
sought to investigate potential prenatal cocaine-induced alter-
ations in auditory information processing in a rodent model
within auditory startle, habituation, and reﬂex modiﬁcation para-
digms. TheASR and its plasticity [habituation, prepulse inhibition
(PPI)] have much to recommend it for drug abuse studies, includ-
ing its rapidity, its objectivity, its sensitivity, and its suitability for
use in both humans and a variety of laboratory animals (Ison,
1984). Accordingly, the goals of the present study were ﬁvefold.
We sought to determine if prenatal cocaine, administered via the
clinically relevant IV route and with doses that mimic the peak
arterial levels of cocaine used by humans (cf. Evans et al., 1996;
Booze et al., 1997): (1) alters the development of the ASR in
preweanling rats, (2) has a long-term effect on the ASR and its
habituation, (3) produces any differential effect on the ASR as a
functionof the sex and/or stage of the estrous cycle of the offspring,
(4) alters the preattentive process of sensory gating as indexed by
PPI, and (5) exerts its effects on the ASR via alterations in the
noradrenergic system.
MATERIALS AND METHODS
ANIMALS
Nulliparous female Long–Evans rats were obtained from Harlan
Sprague-Dawley (Indianapolis, IN, USA) at 11–12weeks of age.
The animals were pair-housed and given ad libitum access to both
food (Purina Rat Chow) and water for 2weeks prior to the begin-
ning of the experiment. The animals weremaintained according to
NIH guidelines in AAALAC-accredited facilities. The animal facil-
ity was maintained at 21± 2˚C, 50± 10% relative humidity, and
had a 12-h light: 12-h dark cycle with lights on at 0700 h (EST).
The protocols for the use of rats in this research were approved by
the university IACUC.
SURGERY
Catheterization of the female rats with a vascular access port was
performed as previously described in detail (Mactutus et al., 1994).
Brieﬂy, animals were anesthetized with a mixture of ketamine
(100mg/kg/ml) and xylazine (3.3mg/kg/ml); this anesthetic mix-
ture was chosen over pentobarbital because of the potent effect of
the latter agent on cytochrome P450 activity (LaBella and Queen,
1993; Loch et al., 1995). A sterile Intracath IV catheter (22 ga.,
Becton/Dickinson and Co., Franklin Lakes, NJ, USA) with a Luer
lock injection cap (Medex Inc., Carlsbad, CA, USA) was tunneled
under the skin from the back (between the shoulder blades) and
inserted into the jugular vein approximately 3mm in the direc-
tion of the right atria. Two sutures were placed on either side of
the catheter to hold the catheter in place. Both the cap and the
catheter were implanted dorsally under the skin in a subcutaneous
pouch. Following the surgery, animals were observed periodically
and returned to the vivarium upon recovery from the anesthe-
sia. The catheters were ﬂushed daily with approximately 0.2ml
of 2.5% heparinized saline and the animals were observed for
any signs of discomfort or behavioral distress. Body weights were
recorded prior to the surgery and daily throughout recovery.
ANIMAL MATING
At 4–7 days following surgery, the females were group-housedwith
males overnight for breeding.Vaginal cytology and the presence of
sperm were checked daily in the females. A sperm positive female
was considered pregnant at gestation day (GD)0 and individu-
ally housed in plastic cages with wood-chip bedding throughout
pregnancy and lactation.
EXPERIMENTAL DESIGN/DRUG TREATMENT
The pregnant catheterized female Long–Evans rats were ran-
domly assigned to one of four treatment groups (ns= 12–13) and
received 0.0 (saline), 0.5, 1.0, or 3.0mg/kg of cocaine hydrochlo-
ride (Sigma, St. Louis, MO, USA). Cocaine and saline injections
were administered in a volume of 1ml/kg, via the intravenous
access port, once per day from GD8–14 and twice per day from
GD15–20.Weights of dams were taken daily. Day of birth was con-
sidered postnatal day 0 (D0). Pups were culled to four males and
four females per liter. Pup body weights were obtained on D1 and
thereafter at weekly intervals.
The IV injection procedure was chosen because it mimics the
rapidly peaking pharmacokinetic proﬁle following inhalation or
IV injection of cocaine in humans (Isenschmid et al., 1992). The
3.0-mg/kg dose produces peak arterial plasma levels that are simi-
lar to those reported for humans IV administered 32mg of cocaine
(Evans et al., 1996; Booze et al., 1997). The acute heart rate and
blood pressure responses in the late gestation pregnant rat are
similar to those produced in a variety of other species (Mac-
tutus et al., 2000). Under experimental conditions, this dose is
self-administered by “users” multiple times in a 2.5-h session
(Fischman and Schuster, 1982), and thus represents a low or
recreational dose, highly relevant to the clinical situation being
modeled. The lower doses (0.5 and 1.0mg/kg) of cocaine in the
male rat also produced peak arterial levels that reasonably approx-
imated the peak arterial levels in humans IV administered 8 or
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16mg of cocaine (Evans et al., 1996; Booze et al., 1997). This regi-
men (route,dose, and rate) produces no evidence of overtmaternal
or fetal toxicity, no maternal seizure activity, no effect on maternal
weight, and no effect on offspring growth or mortality (e.g., Mac-
tutus et al., 1994; Mactutus, 1999; Foltz et al., 2004). Furthermore,
this IV injection procedure does not reduce food intake of dams
even when utilizing a cocaine dose as high as 6mg/kg (Robinson
et al., 1994), precluding the need for pair-fed controls.
APPARATUS
The commercially available startle apparatus (SR-Lab Startle
Reﬂex System, San Diego Instruments, Inc.) was used, but with
a 10-cm thick double-walled, 81-cm× 81-cm× 116-cm isolation
cabinet (external dimensions; Industrial Acoustic Company, INC.,
Bronx,NY,USA), rather than the 1.91-cm thickABSplastic cabinet
offered with this system. The high-frequency loudspeaker of the
SR-Lab system (Radio Shack model #40-1278B, frequency range
of 5–16 kHz) was mounted inside the chamber, 30 cm above the
perspex test cylinder, for delivery of the auditory stimuli. The
perspex test cylinder varied in size with the age of the animal:
3.8 cm internal diameter (ID) for the weanling rats and 8.9 cm ID
for the adult rats. The perspex test cylinder was positioned on a
12.5-cm× 20-cm perspex platform, centrally located within the
test chamber. A piezoelectric accelerometer, permanently afﬁxed
to the base of each perspex cylinder, converted the deﬂection of
the perspex cylinder produced by the animal’s startle response to
an analog signal. All accelerometer signals were then digitized (12
bit A–D) and saved to a hard disk on a Pentium class computer.
Auditory stimulus intensities were measured and calibrated with
a sound level meter (Extech Instruments, Waltham, MA, USA).
Response sensitivities were calibrated using the SR-LAB startle
calibration system.
GENERAL PROCEDURES
For all paradigms, each animal was tested individually in the dark.
All white noise stimuli were passed as broad-band through the
range possible by the horn tweeter (5–16 kHz). This broad-band
white noise spans the peak sensitivity of the audiogram of the
Long–Evans rat at 8 kHz (Heffner et al., 1994). For all paradigms,
the dependent measures collected were peak response amplitude
within a 100-ms sampling window, average response amplitude
across the 100-ms sampling window, and response latency. Within
the constraints of the software, response latency represents the
time from the onset of the startle stimulus to the time of the
peak response, rather than the more traditional deﬁnition of
latency, which would be until the onset of the startle response.
The error introduced by this protocol is estimated to be approxi-
mately 2–3ms,accounting for roughly 10%of the error in response
latency values.
Preweaning ASR and habituation
At 18–20 days of age, one male and one female were randomly
selected for a preweaning assessment. The ASR was tested, for
approximately 11min, using the following parameters: 5min
adaptation, 70 dB(A) background, followed by 36 startle trials,
100 dB(A) white noise stimulus of 20ms duration, and a ﬁxed
10-s intertrial interval (ITI). The startle stimulus intensity was
120 dB(A) at 2.5 cm from the speaker, but 100 dB(A) measured
inside the perspex test cylinder. Habituation across the 36 trials
was examined in six-trial blocks.
Adult ASR and habituation
The adult assessment (D90+) followed the parameters as
described for ASR for each animal’s preweaning assessment.
Adult PPI
The animalswere tested again approximately 14 days later,butwith
the PPI protocol. All rats were tested for approximately 18min.
Only the 3.0-mg/kg prenatal cocaine and vehicle control groups
were tested in PPI. The females were tested in diestrus vs. estrus
to assess any potential inﬂuence of estrous cycle. Under PPI, the
animals received a 5-min adaptation period, followed by six sin-
gle startle only white noise stimuli [100 dB(A), 5–16 kHz], 20ms
duration, as habituation trials with a ﬁxed ITI of 10 s, and then
36 PPI trials [interstimulus intervals (ISIs) of 0, 8, 40, 80, 120, or
4000ms] with a variable ITI of 20 s (range of 15–25 s), assigned by
a Latin-square design. The prepulse stimulus intensity was an 85-
dB(A) white noise stimulus (5–16 kHz) with a duration of 20ms.
The incorporation of a range of ISIs was fundamental to estab-
lishment of a relatively precise and deﬁned response function, and
consequently, a more accurate assessment of response inhibition.
Similar ISIs have been employed in studies of the ontogeny of
PPI (Parisi and Ison, 1979, 1981) as well as alterations in PPI as
a function of developmental drug or toxin exposure (Ison, 1984;
Fitting et al., 2006a,b,c; Lacy et al., 2011); these intervals produced
clear, deﬁnable response inhibition and response latency curves.
Given the constraints of the software regarding the use of any ISI
intervals shorter than the prepulse stimulus duration, the ISI rep-
resented the time from the offset of the prepulse stimulus to the
onset of the startle stimulus.
Adult idazoxan–ASR and habituation
The ﬁnal testing of ASR of each animal occurred at approximately
120 days of age. Each animal received a subcutaneous injection of
0.5mg/kg idazoxan (Sigma, St. Louis,MO,USA), an α2-adrenergic
receptor antagonist, immediately prior to testing. A 10-min adap-
tation period was the only variation to the ASR parameters stated
above; a procedure implemented to permit reasonable absorption
and distribution of the drug.
STATISTICAL ANALYSIS
Weight gains of dams during their gestation period were con-
verted to a percentage of weekly and total weight gain. The litter
parameters of gestation length, number of male and female pups
per litter, and mean D1 body weights of male and female pups
were compared based on litter means. All data were analyzed by
ANOVA techniques (Statistical Solutions Ltd, 2009). Log10 trans-
formations of the peak amplitude response were employed, as
necessary to help provide data that were consistent with the nor-
mality assumption of ANOVA. For repeated measures factors,
either orthogonal decompositions were used for those variables
that classically violate compound symmetry assumptions (e.g.,
trials) or the Greenhouse–Geisser df correction factor was used
(Greenhouse and Geisser, 1959). Tests of simple mains effects and
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speciﬁc linear contrasts were also used to evaluate dose-dependent
and trial-dependent effects of the cocaine treatment, respectively
(Winer, 1971). An α level of p ≤ 0.05 was the signiﬁcance level set
for rejection of the null hypothesis.
RESULTS
OFFSPRING GROWTH
Prenatal IV cocaine, administered from GD8–20, had no adverse
effect on any of thematernal or litter parametersmeasured, includ-
ing maternal weight gain during pregnancy, gestation length, birth
weight of male or females pups, or number of male or female pups
(Table 1; Fs< 1.8). No latent effects of prenatal cocaine on adult
body weight were apparent (Table 2; Fs< 1.0).
ASR-PREWEANLING
The peak amplitude measure of the ASR in the preweanling
rats is portrayed in Figure 1 (36-trial mean) and Figure 2
(habituation across six-trial blocks). Most importantly, speciﬁc
Table 1 | Prenatal treatment (mean±SEM).
Cocaine dose
0.0mg/kg 0.5mg/kg 1.0mg/kg 3.0mg/kg
N 12 13 13 13
Gest.
length
22.0± 0.2 22.0± 0.1 22.1± 0.1 22.1± 0.1
% wt gain 53.5± 3.2 54.8± 2.2 60.7± 2.0 57.7± 2.1
Litter size 10.8± 1.0 11.4± 0.8 11.4± 0.8 11.8± 0.5
D1 wt (g) –
males
7.9± 0.1 7.9± 0.2 8.0± 0.1 8.0± 0.2
D1 wt (g) –
females
7.4± 0.1 7.6± 0.2 7.6± 0.1 7.4± 0.2
No. of
males
5.1± 0.5 5.2± 0.7 6.4± 0.7 5.7± 0.5
No. of
females
5.0± 0.7 6.2± 0.6 5.0± 0.7 6.1± 0.5
No signiﬁcant prenatal treatment effects were present on the maternal/litter
parameters examined (Fs< 1.8).
Table 2 | Adult body weights (g) (mean±SEM).
Cocaine(mg/kg) D100 D140
Male 0.0 475.3± 8.9 577.2± 11.2
0.5 476.1± 11.6 583.4± 14.0
1.0 483.9± 9.0 600.8± 11.6
3.0 469.8± 7.5 582.1± 15.4
Female 0.0 282.8± 3.6 324.4± 5.8
0.5 277.9± 5.3 315.8± 6.0
1.0 291.6± 6.4 329.4± 9.2
3.0 283.7± 4.9 326.2± 6.1
A main effect of sex [F(3,77)= 1270.7, p< 0.0001], but no signiﬁcant main effect
of prenatal cocaine, nor interaction of cocaine with sex of the offspring, were
found on the adult body weight (Fs< 1.0).
FIGURE 1 | Mean (±SEM) peak amplitude of the ASR in the
preweanling rats illustrates the quadratic cocaine dose by offspring
sex interaction [F (1,78)= 5.95, p ≤ 0.017]. For the male offspring the best
ﬁt quadratic function accounted for 91% of the variance across dose; for
the female offspring the best ﬁt quadratic function accounted for 94% of
the variance across dose. A similar ﬁnding of a quadratic cocaine dose by
offspring sex interaction with the average amplitude measure was found
[F (1,78)= 5.0, p ≤ 0.028]; those data are not shown).
FIGURE 2 | Mean (±SEM) peak amplitude of the ASR in the
preweanling rats, illustrated as a function of six-trial blocks, depicts
the retarding of within-session habituation by prenatal IV cocaine.
Comparison of the average prenatal cocaine group habituation with that for
the saline group found a prenatal treatment by six-trial block interaction
[F (1,78)= 2.55, pGG ≤ 0.045], with signiﬁcant group differences apparent on
trial blocks ﬁve and six [F (1,82)= 5.8, p ≤ 0.018 and F (1,82)= 5.1, p ≤ 0.027,
respectively]. The best ﬁt linear regression for the habituation curve of the
saline group accounted for 97% of the variance; the best ﬁt function for the
average cocaine habituation was a quadratic that accounted for >99% of
the variance. A similar pattern of differences is also illustrated when
comparing the low 0.5mg/kg cocaine dose vs. saline.
assessment of dose–response functions indicated a signiﬁcant pre-
natal cocaine dose by offspring sex interaction [quadratic dose by
sex, F(1,78)= 5.95, p ≤ 0.017]. Response amplitude was increased
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>18% for M> F (0.5mg/kg), >30% for M> F (1mg/kg) and
>30% for F>M (3mg/kg). The best ﬁt quadratic function for
males accounted for 91% of the variance (r2 = 0.91), whereas the
best ﬁt quadratic ﬁt for females accounted for 94% of the vari-
ance(r2 = 0.94). A comparable pattern of results was seen with the
average response amplitude measure, with a signiﬁcant prenatal
cocaine dose by offspring sex interaction [quadratic dose by sex,
F(1,78)= 5.0, p ≤ 0.028]; these redundant data are not illustrated.
There were no statistically signiﬁcant effects detectable on aver-
age response latency. The mean (±SEM) response latency across
all pups was 30.6± 0.3ms; all treatment/sex group means were
within the range of 29.1–32.7ms (data not illustrated).
Habituation of theASR across six-trial blocks revealed a promi-
nent linear decrease [F(1,78)= 106.5, p ≤ 0.001] in peak response
amplitude across trials with the contribution of a quadratic com-
ponent [F(1,78)= 10.4, p ≤ 0.002]. A comparison of the average
prenatal cocaine group habituation vs. that for the saline group
revealed a signiﬁcant six-trial block by prenatal treatment interac-
tion [F(1,78)= 2.55, pGG ≤ 0.045], with signiﬁcant group differ-
ences apparent on trial blocks ﬁve and six [F(1,82)= 5.8,p ≤ 0.018
and F(1,82)= 5.1, p ≤ 0.027, respectively]. The best ﬁt linear
regression for the habituation curve of the saline group accounted
for 97%of the variance; the best ﬁt function for the average cocaine
habituation was a quadratic that accounted for 99.6% of the vari-
ance. A comparison of the lowest 0.5mg/kg cocaine dose group vs.
the saline group found a very similar pattern, although the three-
way interaction of six-trial block, prenatal cocaine treatment,
and offspring sex was statistically signiﬁcant [F(5,190)= 3.12,
pGG ≤0.021]. The linear six-trial block byprenatal treatment inter-
action was prominent in males [F(1,38)= 10.10, p ≤ 0.003], but
was not evident in females. Nevertheless, signiﬁcant treatment
group differences (0.5mg/kg cocaine vs. saline) were again sug-
gested on trial blocks ﬁve and six [F(1,38)= 3.91, p ≤ 0.055 and
F(1,38)= 5.0, p ≤ 0.031, respectively].
ASR-ADULT
The peak amplitude measure of the ASR in the adult offspring
is portrayed in Figure 3 (36-trial mean) and Figure 4 (habit-
uation across six-trial blocks). The peak amplitude of the ASR
in the adults displayed an overall effect of prenatal dose of
cocaine [F(3,80)= 6.0, p ≤ 0.001], but neither of sex of the off-
spring nor the interaction of dose and sex approached signiﬁcance
(ps> 0.10). Trend analyses indicated the prenatal treatment factor
displayed a prominent linear dose–response effect [F(1,80)= 14.5,
p ≤ 0.001] with a maximal facilitation of >75%.
The average amplitude of theASR in the offspring as adults also
indicated an augmented overall effect of prenatal dose of cocaine
[F(3,80)= 4.8, p ≤ 0.004], but neither sex of the offspring nor the
interaction of dose and sex approached signiﬁcance (ps> 0.10).
Trend analyses indicated the prenatal treatment factor displayed a
prominent linear dose–response effect [F(1,80)= 11.1, p ≤ 0.001]
with a maximal facilitation of ∼85%; this redundant data is not
illustrated.
There was no overall effect of prenatal dose of cocaine on
peak response latency of the ASR in the offspring as adults
[F(3,80)= 1.5, p> 0.10], sex of the offspring nor on the inter-
action of dose and sex [Fs< 1.0]. Further, trend analyses failed
FIGURE 3 | Mean (±SEM) peak amplitude of the ASR in the offspring
as adults.The effect of prenatal dose of cocaine [F (3,80)= 6.0, p ≤ 0.001]
with a prominent linear dose–response component [F (1,80)= 14.5,
p ≤ 0.001] accounted for 84% of the dose group variance. A similar
prominent linear dose–response effect [F (1,80)= 10.9, p ≤ 0.0015] was
noted on the average amplitude measure (data not shown).
FIGURE 4 | Mean (±SEM) peak amplitude of the ASR in the offspring
as adults shown as a function of six-trial blocks.The best ﬁt function for
the habituation curves of the saline group, the average cocaine group, and
the 0.5-mg/kg cocaine group were each quadratic ﬁts that accounted for
>99% of the variance; Examination of habituation across all prenatal
treatment dose groups revealed signiﬁcant group differences were
apparent on trial blocks one through six, inclusive [Fs(3,80)≥ 2.7, p ≤ 0.05].
Thus, within-session habituation of the ASR in adulthood was also retarded
by prenatal IV cocaine.
to detect any systematic relation among the treatment dose
groups. The mean (±SEM) response latency across all rats was
29.1± 0.6ms; all treatment group means were within the range
of 28.1–31.2ms (data not illustrated). The numeric change as a
function of treatment ranged from between −3 and +8% relative
to vehicle controls.
Habituation of the ASR across six-trial blocks revealed both
prominent linear and quadratic components to the decrease in
peak response amplitude across trials [F(1,80)= 135.6, p ≤ 0.001
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and F(1,80)= 83.2, p ≤ 0.001, respectively]. The best ﬁt func-
tion for the habituation curve of the saline group was a qua-
dratic ﬁt that accounted for >99% of the variance; similarly, the
best ﬁt function for the average cocaine habituation was a qua-
dratic accounting for >99% of the variance; these curves were
signiﬁcantly different (p< 0.001). The best ﬁt function for the
0.5-mg/kg cocaine group also accounted for >99% of the vari-
ance. Examination of habituation across all prenatal treatment
dose groups revealed signiﬁcant group differences were apparent
on trial blocks one through six, inclusive [F(3,80)= 2.8,p ≤ 0.045,
F(3,80)= 7.5, p ≤ 0.001, F(3,80)= 5.6, p ≤ 0.002, F(3,80)= 2.9,
p ≤ 0.039, F(3,80)= 2.8, p ≤ 0.048, F(3,80)= 2.7, p ≤ 0.05]. A
comparison of the average prenatal cocaine group habituation
vs. that for the saline group revealed an overall prenatal cocaine
effect [F(1,84)= 5.9, p ≤ 0.018] with signiﬁcant group differ-
ences apparent on trial blocks two and three [F(1,84)= 10.2,
p ≤ 0.002 and F(1,84)= 6.2, p ≤ 0.014, respectively]. A compari-
son of the lowest 0.5mg/kg cocaine dose group vs. the saline group
found a very similar pattern; signiﬁcant treatment group differ-
ences (0.5mg/kg cocaine vs. saline) were again suggested on trial
blocks two and three [F(1,40)= 7.9, p ≤ 0.008 and F(1,40)= 5.3,
p ≤ 0.026, respectively].
ESTROUS CYCLE
Comparison of the peak response amplitude (mean± SEM:
1227± 166.4 vs. 1355± 176.3), average response amplitude
(280± 26.1 vs. 320± 30.1) and response latency (28.3± 0.76 vs.
29.7± 0.88) in the adult females as a function of stage of the
estrous cycle (diestrus vs. estrus, respectively) demonstrated that
there was no signiﬁcant effect on any of the dependent measures
[Fs(1,20)< 1.1].
PREPULSE INHIBITION
An overall effect of the prenatal dose of cocaine was detected
on peak amplitude on the habituation trials (six-trial average)
of the PPI protocol [F(1,34)= 11.2, p ≤ 0.002], but neither sex
of the offspring nor the interaction of dose and sex were sig-
niﬁcant (ps> 0.10). A marked facilitation was observed in both
the males (65%) and females (55%) that had prenatally received
the 3.0-mg/kg dose of cocaine. The average amplitude mea-
sure displayed a similar prenatal cocaine effect [F(1,34)= 11.3
p ≤ 0.002], with pronounced facilitation in both males (99%) and
female (82%).
The PPI peak response amplitude data from the adult off-
spring is illustrated in Figure 5, across the ISI function. The peak
amplitude on the PPI trials as a function of the ISI (six-trial aver-
age/ISI) showed that the main effects of prenatal treatment and
sex, as well as the interaction of treatment and sex, were not
signiﬁcant. The ISI function was best described by a quadratic
ﬁt [F(1,34)= 138.1 p ≤ 0.001 and F(1,34)= 75.2, p ≤ 0.001, peak
and average amplitude measures, respectively]. Of greater inter-
est, however, a signiﬁcant prenatal treatment effect by prepulse
ISI was observed [F(5,170)= 4.0, pGG ≤ 0.038, with the sugges-
tion of linear and quadratic components F(1,34)= 6.4, p ≤ 0.016
and F(1,34)= 3.8, p ≤ 0.059, respectively]. The average ampli-
tude measure similarly conﬁrmed a signiﬁcant prenatal treatment
by prepulse ISI interaction [F(5,170)= 4.7, pGG ≤ 0.026], with
FIGURE 5 | Mean (±SEM) peak amplitude on the prepulse inhibition
trials as a function of the ISI (six-trial average/ISI). A signiﬁcant prenatal
treatment effect by prepulse ISI was observed [F (5,170)= 4.0, pGG ≤ 0.038].
The characteristic quadratic function across ISIs 8–120, accounted for 88%
of the variance in the control group. In contrast the progressive linear
change in inhibition across ISI for the 3.0-mg/kg prenatal cocaine group
accounted for 67% of the variance. A shift in the peak of inhibition from 40
to 120ms is also apparent.
linear and quadratic components [F(1,34)= 5.6, p ≤ 0.024, and
F(1,34)= 4.6,p ≤ 0.039, respectively]. Speciﬁc examination of the
prepulse trials (ISIs 4–120) noted differential modulation of inhi-
bition by ISI as a function of prenatal cocaine treatment. The
characteristic quadratic function displayed by the saline control
group account for 88% of the variance whereas a linear function
accounted for 67% of the variance for the prenatal cocaine group.
The different functional characterization of the inhibition curve
further demonstrated a shift in the peak of inhibition from 40 to
120ms. The evidence for an effect of prenatal cocaine treatment
on the control trials (0 and 4000ms ISI intervals) was suggested,
but not consistent [peak amplitude, F(1,34)= 3.4, p ≤ 0.072 vs.
average amplitude, F(1,34)= 4.2, p ≤ 0.048]. The calculation of a
percent PPI measure, to take into account any such difference in
the control trials, failed to detect any overall difference in mag-
nitude of inhibition (prenatal saline, 87.2% vs. prenatal cocaine,
87.7%). Thus, although prenatal cocaine exposure did not alter the
derived percent PPI measure, the assessment of inhibition across
ISI displayed a functional alteration in modulation of inhibition
by ISI, in other words, an alteration in sensorimotor gating.
The response latency measure for the PPI paradigm with the
adult offspring is portrayed in Figure 6. An examination of
response latencies across the inhibition trials (8–120ms), where
the functional alterations in response inhibition was noted above,
conﬁrmed therewas a pronounced effect of ISI on response latency
[F(3,102)= 20.5, p ≤ 0.001, with a prominent linear component,
F(1,34)= 44.4, p ≤ 0.001], but ISI did not interact with prena-
tal treatment. Speciﬁcally, all groups generally displayed shorter
latencies with the shorter ISIs. Nevertheless, a signiﬁcant offspring
sex effect [F(1,34= 4.5, p ≤ 0.041] as well as a prenatal treat-
ment by offspring sex interaction [F(1,34)= 5.2, p ≤ 0.030] was
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FIGURE 6 | (A) Mean (±SEM) response latency in as a function of ISI and
sex of the offspring for the prenatal (A) vehicle- and (B) cocaine-treated
animals. A prenatal treatment by offspring sex interaction [F (1,34)= 5.2,
p ≤ 0.030] was observed on the inhibition trials (ISIs of 8–120ms). The
signiﬁcant sex difference in response latency for the saline control group
[F (1,34)= 9.2, p ≤ 0.005] was not present in the prenatal cocaine-treated
adults [F < 1.0]. The most marked treatment group difference in response
latency occurred at the 40-ms ISI [F (1,34)= 8.0, p ≤ 0.008].
observed on the inhibition trials (ISIs of 8–120ms). An exam-
ination of this interaction revealed that there was a signiﬁcant
sex difference in response latency for the saline control group
[F(1,34)= 9.2, p ≤ 0.005], which was not present in the prena-
tal cocaine-treated adults [F < 1.0]. From an alternative view,
there was a signiﬁcant prenatal treatment effect in the male adult
offspring [F(1,34)= 6.6, p ≤ 0.015], but not in the female adult
offspring [F < 1.0]. The locus of these group differences appeared
FIGURE 7 | Mean (±SEM) percent change in the peak amplitude of the
ASR following idazoxan (0.5mg/kg) administration in the adult
offspring shown as a function of prenatal cocaine dose.There was a
signiﬁcant prenatal treatment effect [F (3,79)= 3.1, p ≤ 0.03] which was
characterized by a prominent linear trend [F (1,79)= 8.9, p ≤ 0.004]. A
similar linear trend was shown by the average amplitude response data
[F (1,79)= 4.2, p ≤ 0.043] (not shown).
to be the attributable to the difference in response latency at the
40-ms ISI [F(1,34)= 8.0, p ≤ 0.008].
IDAZOXAN
The percent change in the peak amplitude of the ASR following
idazoxan administration in the adult offspring is displayed as a
function of prenatal cocaine dose in Figure 7. There was a signif-
icant prenatal treatment effect [F(3,79)= 3.1, p ≤ 0.031] which
was characterized by a prominent linear trend [F(1,79)= 8.9,
p ≤ 0.004]. Although an effect of offspring sex approached sig-
niﬁcance [F(1,79)= 3.6, p ≤ 0.062], there was little evidence for
an interaction of prenatal cocaine dose and sex of the offspring
was [F(1,79)= 1.3]. An evaluation of the percent change in the
average amplitude of the ASR conﬁrmed the major ﬁnding of
a differential sensitivity to idazoxan as a linear function of pre-
natal cocaine dose [F(1,79)= 4.2, p ≤ 0.043]. The evidence for
idazoxan-induced changes in response latency [F(3,79)= 3.5,
p< 0.019] displayed a prominent quadratic component across
increasing prenatal cocaine dose [F(1,79)= 9.3. p< 0.003] having
no obvious association with the response amplitude effects of ida-
zoxan. The response latency data (mean± SEM), across increasing
prenatal cocaine dose, were 3.0± 3.1, 8.7± 3.7, 6.4± 4.5, and
−10.3± 7.0%, respectively.
DISCUSSION
Administration of cocaine to pregnant rats from the time of
implantation until parturition produced signiﬁcant alterations in
auditory information processing in the Long–Evans rat within
auditory startle, habituation, and reﬂex modiﬁcation paradigms.
Three prominent effects observed were: (1) the magnitude of
the ASR, as indexed by waveform amplitude, was signiﬁcantly
increased as a function of prenatal dose of cocaine; (2) decreased
rates of within-session habituation were observed at even the low-
est maternally administered dose; and (3) differential sensitivity to
PPI was noted as a function of prenatal cocaine with manipulation
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of the ISI function; this differential sensitivity of the preattentive
process of sensorimotor gating was observed for both response
amplitude and response latency measures. Perhaps more impor-
tantly, (4) signiﬁcant alterations in each of the three paradigms
were found in adulthood, regardless of whether or not there was
evidence available for the persistence, as opposed to a latent emer-
gence,of the effects. Further, (5) an alteration in the function of the
noradrenergic system in adulthood was suggested by the prenatal
cocaine dose-dependent attenuation of the ability of 0.5mg/kg
idazoxan to enhance the ASR. Finally, these alterations in audi-
tory information processing were observed with cocaine being
delivered by the clinically relevant IV route and at physiologi-
cally relevant doses; conditions under which no adverse effects on
maternal/litter parameters were signiﬁcantly altered.
Early clinical data suggested an altered startle reactivity to
a variety of stimuli (e.g., Chasnoff et al., 1985, 1989; Grifﬁth,
1988) may be observed in prenatal cocaine-exposed infants. Sub-
sequent experimental data reported increased responsiveness to
auditory stimuli (Anday et al., 1989); but depressed startle reac-
tivity has also been noted (Mayes et al., 1998). The increased
ASR response presently reported during the preweaning period
(∼30%) and in adulthood (>75%) was particularly notable in
light of the relatively modest, if any, changes available in the
literaturewith rodentmodels (Foss andRiley, 1988, 1991a,b;Dow-
Edwards and Hughes, 1995; Vorhees et al., 1995, 2000; Hughes
et al., 1996). In the initial, preliminary study, the ASR of pre-
natal cocaine rats (60mg/kg/day, peroral (PO) route, GD14–21)
was enhanced at 90, but not at 60, days of age (Foss and Riley,
1988). However, a very systematic replication study by the same
laboratory, with the addition of pair-fed controls, and a second
set of rats administered cocaine via the subcutaneous (SC) route
(40mg/kg/day, GD8–21) failed to ﬁnd any signiﬁcant changes in
the ASR, in startle habituation, or in reﬂex modiﬁcation tests that
could be attributed to prenatal exposure to cocaine (Foss and
Riley, 1991a). Not surprisingly, prenatal cocaine during a more
restricted period of gestation (GD14–21, SC route) also failed to
signiﬁcantly affect the peak ASR in adult rats (Foss and Riley,
1991b). Repeated daily dosing (ﬁve doses/day× 20mg/kg/dose)
on GD7–12 or GD13–18, failed to affect the ASR on D50–52
(Vorhees et al., 1995). In the one “positive” peer-reviewed prena-
tal study, cocaine administered intragastric (IG; GD8–22) failed
to affect the peak ASR at 60 days of age, although there was
a small, statistically signiﬁcant decrease in the ASR of females
(Hughes et al., 1996). Even the neonatal rat model, promoted
to more speciﬁcally mimic fetal brain exposure to cocaine dur-
ing the third trimester of human pregnancy (Dobbing and Sands,
1979), has provided, at best, equivocal results (Dow-Edwards and
Hughes, 1995; Vorhees et al., 2000). Comparing D1–10 vs. D11–
20 treatment with cocaine revealed no signiﬁcant alteration in
the ASR on an initial test at 60–65 days of age (Dow-Edwards
and Hughes, 1995). In the “positive” study, neonatal cocaine-
treated rats (60mg/kg, SC, PND 1–10) showed a signiﬁcantly
augmented (∼30%) peak ASR at D50–52; however, an analysis
of covariance adjusting for signiﬁcant cocaine-induced decreases
in body weight, reduced the augmentation to a statistically non-
signiﬁcant level (Vorhees et al., 2000). Clearly, there are neither
striking nor consistent positive data within the extant rodent
models to corroborate the clinical in utero cocaine effects on the
infant ASR.
Dose-dependent alterations in the ASR characterized by prena-
tal cocaine treatment were apparent during both the preweaning
period and in adulthood. The early alterations in the ASR were
differently expressed dependent upon the sex of the offspring. Pre-
natal cocaine-exposed males were most adversely affected by the
low and middle doses of cocaine, as reﬂected in a quadratic dose–
response ﬁt, whereas the females were most adversely affected by
the high-dose of cocaine, as reﬂected in a growth curve ﬁt. In adult-
hood, a linear dose–response function, independent of offspring
sex, captured 94% of the variance in ASR amplitude. The presence
of a sex-dependent effect of cocaine well before puberty, but not
in adulthood, on the same dependent measure suggests the likeli-
hood of an organizational effect on the brain (Gorski et al., 1975).
The consequences of such an organizational effect are not readily
revealed as a function of ASR testing of the adult females in estrus
vs. diestrus vs. males. Nevertheless, as discussed in detail below,
the pronounced prenatal cocaine by sex interaction on response
latency in the PPI paradigm iswholly consistentwith such an effect
on early brain development.
Deﬁcits in auditory information processing, characterized by
impaired habituation in prenatal cocaine-exposed neonates, were
reported using habituation and recovery of head-turning toward
an auditory stimulus (Potter et al., 2000). The response pattern of
the prenatal cocaine-exposed infants was consistent with a slower
speed on auditory information processing. Cocaine-exposed new-
borns showed inferior performance on the habituation cluster of
theBrazelton scale, requiringmore trials than controls to habituate
to auditory (as well as visual and tactile) stimuli (Eisen et al., 1991).
The presently reported alterations in within-session habituation
detected during the preweaning period as well as in adulthood
were also especially notable in light of the paucity of such infor-
mation in the preclinical literature. No differences were seen as a
function of prenatal cocaine in rate of habituation to a pulsing tone
in assessment of the heart rate orienting response in preweanling
rats (Heyser et al., 1994). Impaired between-session habituation at
60–65 days of age was found following neonatal cocaine exposure
on D1–10; ASR amplitude was higher throughout session 2 than
session 1, however, the polynomial ﬁt across startle trials did not
differentiate the prenatal treatments (Dow-Edwards and Hughes,
1995).
The use of the relatively short ITI, to facilitate within-session
habituation,was able to differentiate habituation between prenatal
cocaine vs. vehicle controls in the preweaning period. The linear
habituation in controls contrasts sharply with the best ﬁt qua-
dratic function in prenatal cocaine animals, reﬂecting their failure
to show progressive habituation throughout the ASR session. In
adulthood a similar differentiation of within-session habituation
was apparent. The very rapid decrease in response amplitude to a
plateau after the ﬁrst six-trial block in controls is markedly distinct
from the gradual curvilinear process observed with the prenatal
cocaine-exposed adults. Perhaps of greater note, at both test ages,
the overall cocaine effect was readily apparent with the lowest
administered dose. It will be of great interest to ascertain the gen-
erality of this impaired habituation with tactile startling stimuli,
such as with an air-puff.
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Reﬂex modiﬁcation procedures have much to recommend it
for drug abuse studies in both humans and a variety of labora-
tory animals (Ison, 1984). The preattentive processes underlying
reﬂex modiﬁcation procedures, such as PPI, are presumed to pro-
tect encoding by gating out other stimulation that occurs in close
temporal proximity to the initial stimulus; i.e., attenuated PPI
would suggest less efﬁcient gatingmechanisms (Hoffmanand Ison,
1980; Ison and Hoffman, 1983). In the only clinical reﬂex mod-
iﬁcation study of which we are aware, prenatal cocaine-exposed
infants displayed an exaggerated glabellar reﬂex when the tap was
accompanied by a tone (Anday et al., 1989). Although more reﬂex
modiﬁcation studies are available in the preclinical literature, they
have consistently failed to ﬁnd signiﬁcant alterations in PPI.
Presently, the differential sensitivity to PPI observed as a func-
tion of prenatal cocaine was revealed by systematic manipulation
of the ISI function; this differential sensitivity of the preattentive
process of sensorimotor gating was observed for both response
amplitude and response latency measures. It is of interest that
the commonly reported metric for response amplitude, percent-
age PPI, was not altered by the prenatal cocaine treatment when
tested in adulthood. However, the incorporation of a reason-
ably complete ISI function was sensitive to revealing alterations
in sensorimotor gating. In contrast to the characteristic curvilin-
ear function relating PPI to ISI, as seen with other stimulants or
toxic proteins (e.g., Ison, 1984; Fitting et al., 2006a,b,c; Lacy et al.,
2011), the prenatal cocaine-exposed adults displayed a progressive
increase in PPI as the ISI increased throughout the range examined
(8–120ms). Thus, the temporal process of sensorimotor gating, as
revealed by manipulation of ISI, appeared adversely affected by
the prenatal cocaine treatment.
Alterations in response latencies during PPI were striking,
particularly in light of the alterations in the brainstem evoked
potential alteration reported in human infants (Shih et al., 1988;
Salamy et al., 1990; Cone-Wesson and Spingarn, 1993; Lester et al.,
2003; Tan-Laxa et al., 2004). The response latencies on PPI latency
trials of the saline animals demonstrated a clear sex-dependent
pattern whereas those of the prenatal IV cocaine-exposed males
and females failed to display any signiﬁcant variation as a func-
tion of sex. Again, of the limited prior rodent studies, either no
signiﬁcant alterations were observed in prenatal cocaine-exposed
animals on any measure of PPI (Foss and Riley, 1991a; Vorhees
et al., 1995, 2000), or a small, albeit statistically signiﬁcant increase
in the magnitude of PPI was reported compared to controls (rela-
tive difference of 8%) at 50–60 days of age (30mg/kg/day cocaine
on GD1–20; Hughes et al., 1996).
One factor that differed between the present and prior studies
is that the cocaine was delivered to the dam by different routes of
administration, IV vs. SC or PO. IV injection is one of the most
clinically relevant routes; stimulant abuse liability is a function of
the rapiditywithwhich the drug reaches the brain (e.g.,Russell and
Feyerabend, 1978; Henningﬁeld and Keenan, 1993; Abreu et al.,
2001); a consequence not unexpected given that rate of IV drug
delivery is well-established to increase maximum arterial drug
concentration (Gibaldi, 1991). Furthermore, IV maternal admin-
istrationof cocainenot only results in signiﬁcant fetal plasma levels
of cocaine (3mg/kg – 300 ng/ml; 6mg/kg – 500 ng/ml – Robinson
et al., 1994),but also an appreciable tissue uptake of cocaine by fetal
brain (at least under a repeated daily dosing regimen; Robinson
et al., 1994). Moreover, unlike the SC and PO routes of admin-
istration (Spear et al., 1989a; Dow-Edwards, 1990), the IV route
is associated with a rapid elimination of cocaine from fetal brain
(Robinson et al., 1994). Thus, the fetus is rapidly and transiently
exposed to signiﬁcant amounts of cocaine using the IV dosing
model.
The pharmacokinetic proﬁle of near instantaneous distrib-
ution and short half-life for IV cocaine in rats closely mimics
that observed in humans following inhalation or IV injection of
cocaine (Evans et al., 1996; Booze et al., 1997). In contrast, the
pharmacokinetics of cocaine delivered by the SC route involves
a prolonged absorption process as well as a protracted elimina-
tion half-life (Collins et al., 1999). Second, the doses of cocaine
employed in the current study are not only 1–2 orders of mag-
nitude less than that employed with SC or PO dosing, but are
known to produce arterial plasma levels of cocaine comparable
to that of humans provided recreational doses of cocaine (Evans
et al., 1996). Furthermore, the IV model precludes the poten-
tial confounds of cocaine-induced necrotic lesions characteristic
of other routes of administration (e.g., intranasal, SC, Bruckner
et al., 1982) and the possibility of extraplacental fetal absorption of
cocaine (SC, Lipton et al., 1998). Third, the animals in the present
study were tested beginning at 90 days of age vs. 50–60 used in
many of the prior studies. Although there have been clear onto-
genetic drifts in physiological proﬁles, at least historically, vaginal
opening of LE female rats occurred at approximately D72 with
maximum fertility achieved at D100–D300 (Farris, 1949); it may
be prudent to refrain from labeling 50 to 60-day-old LE rats as
adults.
Pretreatment with an acute low dose of idazoxan at 120 days
of age signiﬁcantly enhanced the magnitude of the ASR, but as
the dose of prenatal IV cocaine increased, less enhancement of
the ASR was observed. The enhancement of the ASR by ida-
zoxan, an α2-adrenergic receptor antagonist, was expected based
upon the well-characterized anatomy and pharmacology of the
ASR (Davis, 1984; Yeomans and Frankland, 1996). Idazoxan may
affect noradrenergic activity via pre-synaptic and/or postsynaptic
actions, since α2-receptors (the drug’s binding site) are localized
both pre- and post-synaptically (Nicholas et al., 1996; Docherty,
1998). Idazoxan blockade of pre-synaptic α2-receptors increases
NE release due to a reduction in NE-mediated negative feedback,
whereas idazoxan’s blockade of postsynaptic α2-receptors antag-
onizes the effects of released NE at synapses with post-junctional
α2-receptors. The marked stimulation of the ASR in control ani-
mals (>225%) is consistent with a pre-synaptic “stimulatory”
effect and an increase in LC ﬁring and release of NE (Freedman
and Aghajanian, 1984; Dennis et al., 1987). Moreover, previous
work suggests that idazoxan speciﬁcally altered selective attention
in a distraction task that also revealed altered selective attention
in rats exposed to cocaine prenatally (Bunsey and Strupp, 1995;
Bayer et al., 2002). Prenatal IV cocaine exposure results in a persis-
tent alteration in forebrain NE systems as indicated by alterations
in receptor density in adolescent (D35; Booze et al., 2006) and
adult (D395) rats (Ferris et al., 2007). The sex-dependent nature of
these alterations in receptor proteins is of note, particularly given
the striking sex-dependent alterations in PPI response latencies,
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as discussed above. Collectively, the above ﬁndings suggest that
the enduring changes produced by prenatal cocaine in the ASR
and its plasticity may be due to underlying changes in the ceu-
ruleocortical NE system. These data are important as they suggest
that the increased reactivity seen in the prenatal cocaine-exposed
animals was attributable to dysfunction in the descending NE
system.
Speciﬁc effects of idazoxan in a distraction task have been pre-
viously shown in adult offspring, following maternal IV cocaine,
without similarly affecting vigilance implicating endogenous nor-
epinephrine inﬂuences on distractibility and/or selective attention
(Bayer et al., 2002). The pattern of results and the speciﬁcity of
the IDZ dose effect rules out non-speciﬁc alterations in perfor-
mance (Bunsey and Strupp, 1995). Given that the noradrenergic
system appears to be involved in the focusing of attention, possi-
bly by attenuating distraction caused by irrelevant stimuli (Coull,
1994;Aston-Jones andCohen, 2005), these data suggest alterations
in the ascending noradrenergic system provide the basis for this
“distracting” effect.
Traditionally, the actions of cocaine have been attributed to
non-selective inhibition of catecholaminergic neurotransmitter
reuptake systems. However, emerging evidence supports the view
that cocaine may have non-traditional mechanisms for its effects
on neuron function (Snow et al., 2001, 2004; Dey et al., 2006).
In both in vitro and in vivo studies noradrenergic neurons of the
locus coeruleus were exposed to cocaine at a physiologically rele-
vant concentration, and for the in vivo studies via the clinically
relevant IV route of administration (Evans et al., 1996; Booze
et al., 1997). Following 7 days of in vitro administration, cocaine
decreased cell survival as well as neurite elongation in compari-
son to vehicle controls (Snow et al., 2001, 2004). In subsequent
studies, cocaine exposure in vitro induced apoptosis in fetal LC
neurons putatively regulated by Bax, via activation of caspases and
their downstream target proteins (Dey et al., 2006; Dey and Snow,
2007). The results were obtained from 7 days of cocaine admin-
istration (in vitro); a longer term exposure might augment the
adverse neuronal effects. These data suggest a decreased ability of
LC neurons to network with target cells through both ascending
(attention/distraction task with idazoxan challenge, Bayer et al.,
2002) and descending (present auditory startle and idazoxan chal-
lenge studies) NE pathways, where damage to the NE cell bodies
of the LC might provide a unifying mechanism underlying these
widespread effects.
Importantly, our evidence for an alteration in the cocaine-
exposed offspring’s processing of novel auditory information was
detected in the absence of any support for the contribution of
indirect effects on maternal growth and nutrition. The IV admin-
istration of cocaine to pregnant rats during the last 2 weeks of
gestation produced no detectable evidence of toxicity in either the
dams or the offspring. A similar failure to ﬁnd evidence of mater-
nal or fetal toxicity attributable to cocaine, when delivered via the
IV route, was previously reported (Mactutus et al., 1994; Mactu-
tus, 1999; Foltz et al., 2004). This negative ﬁnding is also consonant
with several other studies in rats, mice, and rabbits, all of which
have employed IV cocaine doses greater than or equal to those
employed here (Mehanny et al., 1991; Kunko et al., 1993; Robin-
son et al., 1994; Murphy et al., 1997). Together, these observations
argue that the IV route of exposure does not require the use of
pair-fed nutritional controls as, unlike the SC (Church et al., 1988;
Spear et al., 1989b) or PO (Dow-Edwards et al., 1989; Hutch-
ings et al., 1989) models, there appear to be no detectable effects
on pregnancy weight gain, putatively the most sensitive routine
measure of maternal health. Thus, it is tempting to speculate that
the effects of maternal IV cocaine may satisfy the conditions of a
pure neurobehavioral teratogen. Nevertheless, higher IV doses of
cocaine, as typically delivered to pregnant rabbits (4mg/kg 2× day,
Harvey, 2004) causes a loss of approximately half of the kits within
the ﬁrst postnatal week (Murphy et al., 1997); no such effects have
ever been reported with the 3-mg/kg 2× dose as employed by
others that use the IV rabbit model (e.g., Stanwood and Levitt,
2007).
Despite the growing and converging evidence for a primary
effect of prenatal IV cocaine on the LC and noradrenergic sys-
tem, alterations in dopaminergic systems may also be contributing
to the pattern of observed results, i.e., idazoxan may conceivably
be altering norepinephrine-modulated release of dopamine from
the ventral tegmental area and/or substantia nigra (Gresch et al.,
1995; Devoto et al., 2004). Nevertheless, such an effect would
remain consistent with a primary effect of prenatal IV cocaine
on the noradrenergic system. When a direct comparison of poten-
tial noradrenergic vs. dopaminergic system alterations has been
made, dissociations of the effects on prenatal IV cocaine on nora-
drenergic vs. dopaminergic systems are observed, e.g., on neurite
outgrowth (Dey et al., 2006) and apoptotic signaling (Dey et al.,
2007). Future studies that manipulate the timing of gestational
cocaine exposure may permit further dissociation of the effects on
noradrenergic vs. dopaminergic systems.
Finally, while there is very good reason to believe that the
reported alterations are attributable to direct effects of cocaine
on the developing fetus, one must acknowledge the possibility
that there was also some contribution of altered maternal care
that may have contributed to the alterations noted in the off-
spring, i.e., the offspring were not fostered to non-exposed dams
at birth. However, we have purposely used a low dose of cocaine
in our research program to preclude effects on maternal nutri-
tion and pregnancy weight gain, and on fetal growth. We have
never been interested in a high-dose model which would con-
foundnutritional effectswith other direct effects of cocaine.Across
the studies of the past 15 years in which we have performed
research with prenatal cocaine, we have never seen an adverse
effect of prenatal cocaine on offspring growth (often touted as
one of the most sensitive variables one can measure) implicating
any impairment in maternal care. Further, in light of the half-
life of cocaine in the rat when delivered via the IV route (Booze
et al., 1997), one would not expect the presence of cocaine in
the maternal compartment on the day the animals gave birth.
Finally, the dosage regimen employed has no detectable effects
on maternal retrieval in newborn pups (unpublished observa-
tions), again suggesting the low dosages of cocaine employed with
the IV route are not consistent with any impairment in maternal
care.
In sum, the ASR and its plasticity (habituation, PPI) were sen-
sitive to revealing teratogenic effects of cocaine when delivered
by the clinically relevant IV route and at physiologically relevant
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doses. These conditions produced no detectable adverse effects on
maternal/litter parameters. Signiﬁcant alterations in each of the
three paradigms were found in adulthood, regardless of whether
or not there was evidence available for the persistence, as opposed
to a latent emergence, of the effects. Functional alteration of the
noradrenergic system in adulthood was suggested by the prena-
tal cocaine dose-dependent attenuation of the ability of 0.5mg/kg
idazoxan to enhance the ASR. Thus, in utero exposure to cocaine,
when delivered via a protocol designed to capture prominent fea-
tures of recreational usage, causes persistent, if not permanent,
alterations in auditory information processing, and suggests dys-
function of the central noradrenergic circuitry modulating, if not
mediating, these responses.
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